New method predicts if COVID-19 clinical trials will be completed or suspended

Sumary of New method predicts if COVID-19 clinical trials will be completed or suspended:

  • In order to win the battle against COVID-19, studies to develop vaccines, drugs, devices and re-purposed drugs are urgently needed.
  • Randomized clinical trials are used to provide evidence of safety and efficacy as well as to better understand this novel and evolving virus.
  • As of July 15, more than 6,180 COVID-19 clinical trials have been registered through ClinicalTrials.
  • gov, the national registry and database for privately and publicly funded clinical studies conducted around the world.
  • Researchers from Florida Atlantic University’s College of Engineering and Computer Science are the first to model COVID-19 completion versus cessation in clinical trials using machine learning algorithms and ensemble learning.
  • The study, published in PLOS One, provides the most extensive set of features for clinical trial reports, including features to model trial administration, study information and design, eligibility, keywords, drugs and other features.
  • This research shows that computational methods can deliver effective models to understand the difference between completed vs.
  • In addition, these models also can predict COVID-19 trial status with satisfactory accuracy.

Want to know more click here go to source.

From -

Generic selectors
Exact matches only
Search in title
Search in content

Site Language

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.